ArticleOncoimmunology2024

Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade.

Francois Xavier Rwandamuriye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.